论文部分内容阅读
目的探讨血液光量子疗法治疗格林—巴利综合征的临床价值。方法应用血液光量子疗法合并皮质类固醇激素治疗46例GBS患者与单用皮质类固醇治疗38例GBS患者的临床疗效对比。结果治疗组有效率91.3％，对照组为73.7％。治疗组平均疗程比对照组缩短2.3wk。尤其治疗组极重型病例病死率明显降低。结论血液光量子疗法能加快GBS患者神经组织恢复速度，显著降低病死率。减轻皮质类固醇激素副作用，改善心、肺并发症。
Objective To investigate the clinical value of blood photon therapy in treatment of Guillain-Barre syndrome. Methods The clinical efficacy of photoplethysmography plus corticosteroids in treating 46 patients with GBS and 38 patients with GBS treated with corticosteroid alone was compared. Results The effective rate was 91.3% in the treatment group and 73.7% in the control group. The average treatment group than the control group shortened 2.3wk. In particular, the treatment group of extremely heavy case fatality rate was significantly reduced. Conclusion Blood photon therapy can accelerate the recovery of nerve tissue in patients with GBS and significantly reduce the mortality. Reduce the side effects of corticosteroids, improve heart and lung complications.